Byron Brannon
About Byron Brannon
Byron Brannon is the Director of Strategic Finance at OneOncology, where he has worked since 2023. He has a background in finance and healthcare, with previous roles at Goldman Sachs and EY, and holds multiple degrees from Indiana University Bloomington and Columbia University.
Current Role at OneOncology
Byron Brannon serves as the Director of Strategic Finance at OneOncology, a position he has held since 2023. In this role, he is responsible for overseeing financial strategies and initiatives that support the organization's mission in oncology care. His work is based in Nashville, Tennessee, where he contributes to the financial planning and analysis efforts that drive the company's growth and operational efficiency.
Previous Experience at Goldman Sachs
Before joining OneOncology, Byron Brannon worked at Goldman Sachs as an Associate from 2018 to 2019. During his tenure in the Greater New York City Area, he gained experience in financial services, focusing on investment strategies and client relations. This role provided him with a solid foundation in finance and investment banking.
Education and Expertise
Byron Brannon holds a Bachelor of Arts in Accounting and Finance from Indiana University Bloomington, where he studied from 2009 to 2013. He furthered his education at Columbia University, earning a Master of Public Administration in International Finance and Economic Policy from 2020 to 2021. Additionally, he completed a Master of Public Health in Healthcare Policy & Management at Columbia University Mailman School of Public Health from 2021 to 2022. His educational background equips him with a comprehensive understanding of finance and healthcare policy.
Career in Healthcare Finance
Byron Brannon has extensive experience in healthcare finance. He worked at EY in Transaction Advisory Services - Healthcare from 2013 to 2018, where he focused on financial advisory for healthcare clients. Following this, he served as a Healthcare Consultant at Sachs Policy Group for 10 months in 2022 and briefly worked in Healthcare Investment Banking at Bryan, Garnier & Co for 4 months in 2022. His roles have contributed to his expertise in financial strategies within the healthcare sector.